美股周四早盘,基因编辑公司CRISPR Therapeutics(CRSP)下跌1.7%,此前该公司提交文件,计划出售最多6亿美元的普通股,利用其现有的公开市场销售协议。此举旨在加强其财务状况,以推进其研发管线。

本文地址: http://www.jiaotongmi.com/article/20161.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-11-03admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-09-08admin
2025-09-13admin
2025-09-08admin
2025-09-17admin
2025-09-08admin
2025-09-17admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-16admin
2025-09-08admin
2025-09-08admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-09admin
2025-09-08admin
2025-09-16admin
2025-09-11admin
扫码二维码
获取最新动态
